INSIGHTS ON CLINICAL TRIAL PARTNERING

• Empowering Mid-Size Pharma Companies With Integrated Drug Development, Regulatory Strategy, And AI Innovation

  A consultative, tech-enabled CRO can help mid-size pharma achieve targets by supplementing skillsets, expanding global reach, and designing an effective clinical, regulatory, and operational strategy.

• Targeted Modalities: Trends, Challenges, CDMO Considerations

  Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.

• Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective

  Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.

• Price Matters - Why Dash Believes In Transparency

  Opaque pricing slows decisions and erodes trust. Transparency clarifies cost drivers, improves budgeting, enables confident sourcing, and strengthens long-term R&D partnerships.

• How Remote Monitoring Is Transforming Compliance

  5/8/2026

  Discover how remote monitoring is transforming pharmacy compliance. Shift from manual, onsite burdens to digital workflows that ensure real-time accuracy and continuous audit readiness.

• Why ddPCR Is Becoming The Standard For Gene Therapy Biodistribution

  3/9/2026

  ddPCR is becoming essential for biodistribution because it delivers precise, low‑copy quantification qPCR can’t reliably match. Sponsors need partners with true ddPCR depth to ensure consistent, defensible data across tissues and studies.

• What The Suvoda-Greenphire Merger Means For Clinical Trials

  2/18/2026

  Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.

• Prospecting Biospecimen Collections To Power Precision Medicine

  10/15/2025

  High-quality biospecimens are the foundation of precision medicine success. Learn the five crucial steps—from planning to compliance—for a prospective biospecimen collection that is scientifically robust and accelerates your research.

• Central eSource: Leveraging Site Technology

  2/27/2025

  In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.